Monday, August 24, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 19, 2026

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

View original at finance.yahoo.com
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, s…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The total alopecia areata treatment market size is expected to grow positively by 2036 in the leading markets

    80% confidence

  • Despite advancements, a substantial unmet need persists, as currently available treatments do not consistently deliver durable or complete disease control across patient populations

    80% confidence

  • In 2025, the total diagnosed prevalent cases of alopecia areata in the 7MM were found to be 1.7 million

    80% confidence

  • The entry of new therapies under development is expected to intensify competition and may reduce the market share of established treatments like LITFULO and OLUMIANT over time

    80% confidence

  • The United States accounts for the largest market size of alopecia areata, in comparison to EU4, the UK, and Japan

    80% confidence

  • A limited number of therapies are currently approved for the treatment of alopecia areata, underscoring the field's strong emphasis on immune-modulating mechanisms

    80% confidence

  • In 2024, the United States recorded approximately 620K diagnosed cases of alopecia areata

    80% confidence

  • Prevalent cases of alopecia areata in the US accounted for nearly 35% of cases in the 7MM

    80% confidence

Cited in these Via News reports